ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bulk API Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-1E17392
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Bulk API Market Research Report 2024
BUY CHAPTERS

Global Bulk API Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-1E17392
Report
October 2025
Pages:160
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Mallinckrodt Pharmaceuticals
IOL
Granules India
BASF AG
Novacyl
Sichuan Kelun Pharmaceutical
Shandong Lukang Pharmaceutical
CSPC Pharmaceutical
Harbin Pharmaceutical
North China Pharmaceutical
Shandong Xinhua Pharmaceutical
Northeast Pharmaceutical
United Laboratories
Apeloa Pharmaceutical
Zhejiang Anglikang Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Tianyu Pharmaceutical
Shenzhen Hepalink Pharmaceutical

Bulk API Market

The global Bulk API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Bulk APIs refer to traditional chemical APIs such as penicillin, vitamins, and hormones that are of large tonnage and do not involve patent issues. The characteristics of this product are large output, many manufacturing companies, fierce market competition, and low product price and added value.
From a downstream perspective, Prescription Drugs accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Bulk API leading manufacturers including Mallinckrodt Pharmaceuticals, IOL, Granules India, BASF, Novacyl, Sichuan Kelun Pharmaceutical, Shandong Lukang Pharmaceutical, CSPC Pharmaceutical, Harbin Pharmaceutical, North China Pharmaceutical, etc., dominate supply; the top five capture approximately % of global revenue, with Mallinckrodt Pharmaceuticals leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Bulk API market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Bulk API Market Report

Report Metric Details
Report Name Bulk API Market
Segment by Type
  • Vitamins
  • Antibiotic
  • Antipyretic and Analgesic
  • Corticoids
  • Others
Segment by Application
  • Prescription Drugs
  • OTC Drugs
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Mallinckrodt Pharmaceuticals, IOL, Granules India, BASF, Novacyl, Sichuan Kelun Pharmaceutical, Shandong Lukang Pharmaceutical, CSPC Pharmaceutical, Harbin Pharmaceutical, North China Pharmaceutical, Shandong Xinhua Pharmaceutical, Northeast Pharmaceutical, United Laboratories, Apeloa Pharmaceutical, Zhejiang AngLiKang Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Tianyu Pharmaceutical, Shenzhen Hepalink Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Bulk API study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Bulk API Market report?

Ans: The main players in the Bulk API Market are Mallinckrodt Pharmaceuticals, IOL, Granules India, BASF, Novacyl, Sichuan Kelun Pharmaceutical, Shandong Lukang Pharmaceutical, CSPC Pharmaceutical, Harbin Pharmaceutical, North China Pharmaceutical, Shandong Xinhua Pharmaceutical, Northeast Pharmaceutical, United Laboratories, Apeloa Pharmaceutical, Zhejiang AngLiKang Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Tianyu Pharmaceutical, Shenzhen Hepalink Pharmaceutical

What are the Application segmentation covered in the Bulk API Market report?

Ans: The Applications covered in the Bulk API Market report are Prescription Drugs, OTC Drugs

What are the Type segmentation covered in the Bulk API Market report?

Ans: The Types covered in the Bulk API Market report are Vitamins, Antibiotic, Antipyretic and Analgesic, Corticoids, Others

1 Study Coverage
1.1 Introduction to Bulk API: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Bulk API Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Vitamins
1.2.3 Antibiotic
1.2.4 Antipyretic and Analgesic
1.2.5 Corticoids
1.2.6 Others
1.3 Market Segmentation by Application
1.3.1 Global Bulk API Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Prescription Drugs
1.3.3 OTC Drugs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Bulk API Revenue Estimates and Forecasts 2020-2031
2.2 Global Bulk API Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Bulk API Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Bulk API Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Vitamins Market Size by Players
3.3.2 Antibiotic Market Size by Players
3.3.3 Antipyretic and Analgesic Market Size by Players
3.3.4 Corticoids Market Size by Players
3.3.5 Others Market Size by Players
3.4 Global Bulk API Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Bulk API Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Bulk API Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Bulk API Market Size by Type (2020-2031)
6.4 North America Bulk API Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Bulk API Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Bulk API Market Size by Type (2020-2031)
7.4 Europe Bulk API Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Bulk API Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Bulk API Market Size by Type (2020-2031)
8.4 Asia-Pacific Bulk API Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Bulk API Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Bulk API Market Size by Type (2020-2031)
9.4 Central and South America Bulk API Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Bulk API Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Bulk API Market Size by Type (2020-2031)
10.4 Middle East and Africa Bulk API Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Bulk API Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Mallinckrodt Pharmaceuticals
11.1.1 Mallinckrodt Pharmaceuticals Corporation Information
11.1.2 Mallinckrodt Pharmaceuticals Business Overview
11.1.3 Mallinckrodt Pharmaceuticals Bulk API Product Features and Attributes
11.1.4 Mallinckrodt Pharmaceuticals Bulk API Revenue and Gross Margin (2020-2025)
11.1.5 Mallinckrodt Pharmaceuticals Bulk API Revenue by Product in 2024
11.1.6 Mallinckrodt Pharmaceuticals Bulk API Revenue by Application in 2024
11.1.7 Mallinckrodt Pharmaceuticals Bulk API Revenue by Geographic Area in 2024
11.1.8 Mallinckrodt Pharmaceuticals Bulk API SWOT Analysis
11.1.9 Mallinckrodt Pharmaceuticals Recent Developments
11.2 IOL
11.2.1 IOL Corporation Information
11.2.2 IOL Business Overview
11.2.3 IOL Bulk API Product Features and Attributes
11.2.4 IOL Bulk API Revenue and Gross Margin (2020-2025)
11.2.5 IOL Bulk API Revenue by Product in 2024
11.2.6 IOL Bulk API Revenue by Application in 2024
11.2.7 IOL Bulk API Revenue by Geographic Area in 2024
11.2.8 IOL Bulk API SWOT Analysis
11.2.9 IOL Recent Developments
11.3 Granules India
11.3.1 Granules India Corporation Information
11.3.2 Granules India Business Overview
11.3.3 Granules India Bulk API Product Features and Attributes
11.3.4 Granules India Bulk API Revenue and Gross Margin (2020-2025)
11.3.5 Granules India Bulk API Revenue by Product in 2024
11.3.6 Granules India Bulk API Revenue by Application in 2024
11.3.7 Granules India Bulk API Revenue by Geographic Area in 2024
11.3.8 Granules India Bulk API SWOT Analysis
11.3.9 Granules India Recent Developments
11.4 BASF
11.4.1 BASF Corporation Information
11.4.2 BASF Business Overview
11.4.3 BASF Bulk API Product Features and Attributes
11.4.4 BASF Bulk API Revenue and Gross Margin (2020-2025)
11.4.5 BASF Bulk API Revenue by Product in 2024
11.4.6 BASF Bulk API Revenue by Application in 2024
11.4.7 BASF Bulk API Revenue by Geographic Area in 2024
11.4.8 BASF Bulk API SWOT Analysis
11.4.9 BASF Recent Developments
11.5 Novacyl
11.5.1 Novacyl Corporation Information
11.5.2 Novacyl Business Overview
11.5.3 Novacyl Bulk API Product Features and Attributes
11.5.4 Novacyl Bulk API Revenue and Gross Margin (2020-2025)
11.5.5 Novacyl Bulk API Revenue by Product in 2024
11.5.6 Novacyl Bulk API Revenue by Application in 2024
11.5.7 Novacyl Bulk API Revenue by Geographic Area in 2024
11.5.8 Novacyl Bulk API SWOT Analysis
11.5.9 Novacyl Recent Developments
11.6 Sichuan Kelun Pharmaceutical
11.6.1 Sichuan Kelun Pharmaceutical Corporation Information
11.6.2 Sichuan Kelun Pharmaceutical Business Overview
11.6.3 Sichuan Kelun Pharmaceutical Bulk API Product Features and Attributes
11.6.4 Sichuan Kelun Pharmaceutical Bulk API Revenue and Gross Margin (2020-2025)
11.6.5 Sichuan Kelun Pharmaceutical Recent Developments
11.7 Shandong Lukang Pharmaceutical
11.7.1 Shandong Lukang Pharmaceutical Corporation Information
11.7.2 Shandong Lukang Pharmaceutical Business Overview
11.7.3 Shandong Lukang Pharmaceutical Bulk API Product Features and Attributes
11.7.4 Shandong Lukang Pharmaceutical Bulk API Revenue and Gross Margin (2020-2025)
11.7.5 Shandong Lukang Pharmaceutical Recent Developments
11.8 CSPC Pharmaceutical
11.8.1 CSPC Pharmaceutical Corporation Information
11.8.2 CSPC Pharmaceutical Business Overview
11.8.3 CSPC Pharmaceutical Bulk API Product Features and Attributes
11.8.4 CSPC Pharmaceutical Bulk API Revenue and Gross Margin (2020-2025)
11.8.5 CSPC Pharmaceutical Recent Developments
11.9 Harbin Pharmaceutical
11.9.1 Harbin Pharmaceutical Corporation Information
11.9.2 Harbin Pharmaceutical Business Overview
11.9.3 Harbin Pharmaceutical Bulk API Product Features and Attributes
11.9.4 Harbin Pharmaceutical Bulk API Revenue and Gross Margin (2020-2025)
11.9.5 Harbin Pharmaceutical Recent Developments
11.10 North China Pharmaceutical
11.10.1 North China Pharmaceutical Corporation Information
11.10.2 North China Pharmaceutical Business Overview
11.10.3 North China Pharmaceutical Bulk API Product Features and Attributes
11.10.4 North China Pharmaceutical Bulk API Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Shandong Xinhua Pharmaceutical
11.11.1 Shandong Xinhua Pharmaceutical Corporation Information
11.11.2 Shandong Xinhua Pharmaceutical Business Overview
11.11.3 Shandong Xinhua Pharmaceutical Bulk API Product Features and Attributes
11.11.4 Shandong Xinhua Pharmaceutical Bulk API Revenue and Gross Margin (2020-2025)
11.11.5 Shandong Xinhua Pharmaceutical Recent Developments
11.12 Northeast Pharmaceutical
11.12.1 Northeast Pharmaceutical Corporation Information
11.12.2 Northeast Pharmaceutical Business Overview
11.12.3 Northeast Pharmaceutical Bulk API Product Features and Attributes
11.12.4 Northeast Pharmaceutical Bulk API Revenue and Gross Margin (2020-2025)
11.12.5 Northeast Pharmaceutical Recent Developments
11.13 United Laboratories
11.13.1 United Laboratories Corporation Information
11.13.2 United Laboratories Business Overview
11.13.3 United Laboratories Bulk API Product Features and Attributes
11.13.4 United Laboratories Bulk API Revenue and Gross Margin (2020-2025)
11.13.5 United Laboratories Recent Developments
11.14 Apeloa Pharmaceutical
11.14.1 Apeloa Pharmaceutical Corporation Information
11.14.2 Apeloa Pharmaceutical Business Overview
11.14.3 Apeloa Pharmaceutical Bulk API Product Features and Attributes
11.14.4 Apeloa Pharmaceutical Bulk API Revenue and Gross Margin (2020-2025)
11.14.5 Apeloa Pharmaceutical Recent Developments
11.15 Zhejiang AngLiKang Pharmaceutical
11.15.1 Zhejiang AngLiKang Pharmaceutical Corporation Information
11.15.2 Zhejiang AngLiKang Pharmaceutical Business Overview
11.15.3 Zhejiang AngLiKang Pharmaceutical Bulk API Product Features and Attributes
11.15.4 Zhejiang AngLiKang Pharmaceutical Bulk API Revenue and Gross Margin (2020-2025)
11.15.5 Zhejiang AngLiKang Pharmaceutical Recent Developments
11.16 Zhejiang Huahai Pharmaceutical
11.16.1 Zhejiang Huahai Pharmaceutical Corporation Information
11.16.2 Zhejiang Huahai Pharmaceutical Business Overview
11.16.3 Zhejiang Huahai Pharmaceutical Bulk API Product Features and Attributes
11.16.4 Zhejiang Huahai Pharmaceutical Bulk API Revenue and Gross Margin (2020-2025)
11.16.5 Zhejiang Huahai Pharmaceutical Recent Developments
11.17 Zhejiang Tianyu Pharmaceutical
11.17.1 Zhejiang Tianyu Pharmaceutical Corporation Information
11.17.2 Zhejiang Tianyu Pharmaceutical Business Overview
11.17.3 Zhejiang Tianyu Pharmaceutical Bulk API Product Features and Attributes
11.17.4 Zhejiang Tianyu Pharmaceutical Bulk API Revenue and Gross Margin (2020-2025)
11.17.5 Zhejiang Tianyu Pharmaceutical Recent Developments
11.18 Shenzhen Hepalink Pharmaceutical
11.18.1 Shenzhen Hepalink Pharmaceutical Corporation Information
11.18.2 Shenzhen Hepalink Pharmaceutical Business Overview
11.18.3 Shenzhen Hepalink Pharmaceutical Bulk API Product Features and Attributes
11.18.4 Shenzhen Hepalink Pharmaceutical Bulk API Revenue and Gross Margin (2020-2025)
11.18.5 Shenzhen Hepalink Pharmaceutical Recent Developments
12 Bulk APIIndustry Chain Analysis
12.1 Bulk API Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Bulk API Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Bulk API Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Mallinckrodt Pharmaceuticals
IOL
Granules India
BASF AG
Novacyl
Sichuan Kelun Pharmaceutical
Shandong Lukang Pharmaceutical
CSPC Pharmaceutical
Harbin Pharmaceutical
North China Pharmaceutical
Shandong Xinhua Pharmaceutical
Northeast Pharmaceutical
United Laboratories
Apeloa Pharmaceutical
Zhejiang Anglikang Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Tianyu Pharmaceutical
Shenzhen Hepalink Pharmaceutical
List of Tables
 Table 1. Global Bulk API Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Bulk API Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Bulk API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Bulk API Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Bulk API Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Bulk API Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Bulk API Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Bulk API by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bulk API as of 2024)
 Table 11. Global Bulk API Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Bulk API Companies Headquarters
 Table 13. Global Bulk API Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Bulk API Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Bulk API Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Bulk API Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Bulk API Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Bulk API High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Bulk API Growth Accelerators and Market Barriers
 Table 25. North America Bulk API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Bulk API Growth Accelerators and Market Barriers
 Table 27. Europe Bulk API Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Bulk API Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Bulk API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Bulk API Investment Opportunities and Key Challenges
 Table 31. Central and South America Bulk API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Bulk API Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Bulk API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Mallinckrodt Pharmaceuticals Corporation Information
 Table 35. Mallinckrodt Pharmaceuticals Description and Major Businesses
 Table 36. Mallinckrodt Pharmaceuticals Product Features and Attributes
 Table 37. Mallinckrodt Pharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Mallinckrodt Pharmaceuticals Revenue Proportion by Product in 2024
 Table 39. Mallinckrodt Pharmaceuticals Revenue Proportion by Application in 2024
 Table 40. Mallinckrodt Pharmaceuticals Revenue Proportion by Geographic Area in 2024
 Table 41. Mallinckrodt Pharmaceuticals Bulk API SWOT Analysis
 Table 42. Mallinckrodt Pharmaceuticals Recent Developments
 Table 43. IOL Corporation Information
 Table 44. IOL Description and Major Businesses
 Table 45. IOL Product Features and Attributes
 Table 46. IOL Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. IOL Revenue Proportion by Product in 2024
 Table 48. IOL Revenue Proportion by Application in 2024
 Table 49. IOL Revenue Proportion by Geographic Area in 2024
 Table 50. IOL Bulk API SWOT Analysis
 Table 51. IOL Recent Developments
 Table 52. Granules India Corporation Information
 Table 53. Granules India Description and Major Businesses
 Table 54. Granules India Product Features and Attributes
 Table 55. Granules India Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Granules India Revenue Proportion by Product in 2024
 Table 57. Granules India Revenue Proportion by Application in 2024
 Table 58. Granules India Revenue Proportion by Geographic Area in 2024
 Table 59. Granules India Bulk API SWOT Analysis
 Table 60. Granules India Recent Developments
 Table 61. BASF Corporation Information
 Table 62. BASF Description and Major Businesses
 Table 63. BASF Product Features and Attributes
 Table 64. BASF Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. BASF Revenue Proportion by Product in 2024
 Table 66. BASF Revenue Proportion by Application in 2024
 Table 67. BASF Revenue Proportion by Geographic Area in 2024
 Table 68. BASF Bulk API SWOT Analysis
 Table 69. BASF Recent Developments
 Table 70. Novacyl Corporation Information
 Table 71. Novacyl Description and Major Businesses
 Table 72. Novacyl Product Features and Attributes
 Table 73. Novacyl Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Novacyl Revenue Proportion by Product in 2024
 Table 75. Novacyl Revenue Proportion by Application in 2024
 Table 76. Novacyl Revenue Proportion by Geographic Area in 2024
 Table 77. Novacyl Bulk API SWOT Analysis
 Table 78. Novacyl Recent Developments
 Table 79. Sichuan Kelun Pharmaceutical Corporation Information
 Table 80. Sichuan Kelun Pharmaceutical Description and Major Businesses
 Table 81. Sichuan Kelun Pharmaceutical Product Features and Attributes
 Table 82. Sichuan Kelun Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Sichuan Kelun Pharmaceutical Recent Developments
 Table 84. Shandong Lukang Pharmaceutical Corporation Information
 Table 85. Shandong Lukang Pharmaceutical Description and Major Businesses
 Table 86. Shandong Lukang Pharmaceutical Product Features and Attributes
 Table 87. Shandong Lukang Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Shandong Lukang Pharmaceutical Recent Developments
 Table 89. CSPC Pharmaceutical Corporation Information
 Table 90. CSPC Pharmaceutical Description and Major Businesses
 Table 91. CSPC Pharmaceutical Product Features and Attributes
 Table 92. CSPC Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. CSPC Pharmaceutical Recent Developments
 Table 94. Harbin Pharmaceutical Corporation Information
 Table 95. Harbin Pharmaceutical Description and Major Businesses
 Table 96. Harbin Pharmaceutical Product Features and Attributes
 Table 97. Harbin Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Harbin Pharmaceutical Recent Developments
 Table 99. North China Pharmaceutical Corporation Information
 Table 100. North China Pharmaceutical Description and Major Businesses
 Table 101. North China Pharmaceutical Product Features and Attributes
 Table 102. North China Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. North China Pharmaceutical Recent Developments
 Table 104. Shandong Xinhua Pharmaceutical Corporation Information
 Table 105. Shandong Xinhua Pharmaceutical Description and Major Businesses
 Table 106. Shandong Xinhua Pharmaceutical Product Features and Attributes
 Table 107. Shandong Xinhua Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Shandong Xinhua Pharmaceutical Recent Developments
 Table 109. Northeast Pharmaceutical Corporation Information
 Table 110. Northeast Pharmaceutical Description and Major Businesses
 Table 111. Northeast Pharmaceutical Product Features and Attributes
 Table 112. Northeast Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Northeast Pharmaceutical Recent Developments
 Table 114. United Laboratories Corporation Information
 Table 115. United Laboratories Description and Major Businesses
 Table 116. United Laboratories Product Features and Attributes
 Table 117. United Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. United Laboratories Recent Developments
 Table 119. Apeloa Pharmaceutical Corporation Information
 Table 120. Apeloa Pharmaceutical Description and Major Businesses
 Table 121. Apeloa Pharmaceutical Product Features and Attributes
 Table 122. Apeloa Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. Apeloa Pharmaceutical Recent Developments
 Table 124. Zhejiang AngLiKang Pharmaceutical Corporation Information
 Table 125. Zhejiang AngLiKang Pharmaceutical Description and Major Businesses
 Table 126. Zhejiang AngLiKang Pharmaceutical Product Features and Attributes
 Table 127. Zhejiang AngLiKang Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. Zhejiang AngLiKang Pharmaceutical Recent Developments
 Table 129. Zhejiang Huahai Pharmaceutical Corporation Information
 Table 130. Zhejiang Huahai Pharmaceutical Description and Major Businesses
 Table 131. Zhejiang Huahai Pharmaceutical Product Features and Attributes
 Table 132. Zhejiang Huahai Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. Zhejiang Huahai Pharmaceutical Recent Developments
 Table 134. Zhejiang Tianyu Pharmaceutical Corporation Information
 Table 135. Zhejiang Tianyu Pharmaceutical Description and Major Businesses
 Table 136. Zhejiang Tianyu Pharmaceutical Product Features and Attributes
 Table 137. Zhejiang Tianyu Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 138. Zhejiang Tianyu Pharmaceutical Recent Developments
 Table 139. Shenzhen Hepalink Pharmaceutical Corporation Information
 Table 140. Shenzhen Hepalink Pharmaceutical Description and Major Businesses
 Table 141. Shenzhen Hepalink Pharmaceutical Product Features and Attributes
 Table 142. Shenzhen Hepalink Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 143. Shenzhen Hepalink Pharmaceutical Recent Developments
 Table 144. Raw Materials Key Suppliers
 Table 145. Distributors List
 Table 146. Market Trends and Market Evolution
 Table 147. Market Drivers and Opportunities
 Table 148. Market Challenges, Risks, and Restraints
 Table 149. Research Programs/Design for This Report
 Table 150. Key Data Information from Secondary Sources
 Table 151. Key Data Information from Primary Sources


List of Figures
 Figure 1. Bulk API Product Picture
 Figure 2. Global Bulk API Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Vitamins Product Picture
 Figure 4. Antibiotic Product Picture
 Figure 5. Antipyretic and Analgesic Product Picture
 Figure 6. Corticoids Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Bulk API Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 9. Prescription Drugs
 Figure 10. OTC Drugs
 Figure 11. Bulk API Report Years Considered
 Figure 12. Global Bulk API Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Bulk API Revenue (2020-2031) & (US$ Million)
 Figure 14. Global Bulk API Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global Bulk API Revenue Market Share by Region (2020-2031)
 Figure 16. Global Bulk API Revenue Market Share Ranking (2024)
 Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 18. Vitamins Revenue Market Share by Player in 2024
 Figure 19. Antibiotic Revenue Market Share by Player in 2024
 Figure 20. Antipyretic and Analgesic Revenue Market Share by Player in 2024
 Figure 21. Corticoids Revenue Market Share by Player in 2024
 Figure 22. Others Revenue Market Share by Player in 2024
 Figure 23. Global Bulk API Revenue Market Share by Type (2020-2031)
 Figure 24. Global Bulk API Revenue Market Share by Application (2020-2031)
 Figure 25. North America Bulk API Revenue YoY (2020-2031) & (US$ Million)
 Figure 26. North America Top 5 Players Bulk API Revenue (US$ Million) in 2024
 Figure 27. North America Bulk API Revenue (US$ Million) by Type (2020 - 2031)
 Figure 28. North America Bulk API Revenue (US$ Million) by Application (2020-2031)
 Figure 29. US Bulk API Revenue (2020-2031) & (US$ Million)
 Figure 30. Canada Bulk API Revenue (2020-2031) & (US$ Million)
 Figure 31. Mexico Bulk API Revenue (2020-2031) & (US$ Million)
 Figure 32. Europe Bulk API Revenue YoY (2020-2031) & (US$ Million)
 Figure 33. Europe Top 5 Players Bulk API Revenue (US$ Million) in 2024
 Figure 34. Europe Bulk API Revenue (US$ Million) by Type (2020-2031)
 Figure 35. Europe Bulk API Revenue (US$ Million) by Application (2020-2031)
 Figure 36. Germany Bulk API Revenue (2020-2031) & (US$ Million)
 Figure 37. France Bulk API Revenue (2020-2031) & (US$ Million)
 Figure 38. U.K. Bulk API Revenue (2020-2031) & (US$ Million)
 Figure 39. Italy Bulk API Revenue (2020-2031) & (US$ Million)
 Figure 40. Russia Bulk API Revenue (2020-2031) & (US$ Million)
 Figure 41. Asia-Pacific Bulk API Revenue YoY (2020-2031) & (US$ Million)
 Figure 42. Asia-Pacific Top 8 Players Bulk API Revenue (US$ Million) in 2024
 Figure 43. Asia-Pacific Bulk API Revenue (US$ Million) by Type (2020-2031)
 Figure 44. Asia-Pacific Bulk API Revenue (US$ Million) by Application (2020-2031)
 Figure 45. Indonesia Bulk API Revenue (2020-2031) & (US$ Million)
 Figure 46. Japan Bulk API Revenue (2020-2031) & (US$ Million)
 Figure 47. South Korea Bulk API Revenue (2020-2031) & (US$ Million)
 Figure 48. Australia Bulk API Revenue (2020-2031) & (US$ Million)
 Figure 49. India Bulk API Revenue (2020-2031) & (US$ Million)
 Figure 50. Indonesia Bulk API Revenue (2020-2031) & (US$ Million)
 Figure 51. Vietnam Bulk API Revenue (2020-2031) & (US$ Million)
 Figure 52. Malaysia Bulk API Revenue (2020-2031) & (US$ Million)
 Figure 53. Philippines Bulk API Revenue (2020-2031) & (US$ Million)
 Figure 54. Singapore Bulk API Revenue (2020-2031) & (US$ Million)
 Figure 55. Central and South America Bulk API Revenue YoY (2020-2031) & (US$ Million)
 Figure 56. Central and South America Top 5 Players Bulk API Revenue (US$ Million) in 2024
 Figure 57. Central and South America Bulk API Revenue (US$ Million) by Type (2020-2031)
 Figure 58. Central and South America Bulk API Revenue (US$ Million) by Application (2020-2031)
 Figure 59. Brazil Bulk API Revenue (2020-2025) & (US$ Million)
 Figure 60. Argentina Bulk API Revenue (2020-2025) & (US$ Million)
 Figure 61. Middle East and Africa Bulk API Revenue YoY (2020-2031) & (US$ Million)
 Figure 62. Middle East and Africa Top 5 Players Bulk API Revenue (US$ Million) in 2024
 Figure 63. South America Bulk API Revenue (US$ Million) by Type (2020-2031)
 Figure 64. Middle East and Africa Bulk API Revenue (US$ Million) by Application (2020-2031)
 Figure 65. GCC Countries Bulk API Revenue (2020-2025) & (US$ Million)
 Figure 66. Israel Bulk API Revenue (2020-2025) & (US$ Million)
 Figure 67. Egypt Bulk API Revenue (2020-2025) & (US$ Million)
 Figure 68. South Africa Bulk API Revenue (2020-2025) & (US$ Million)
 Figure 69. Bulk API Industry Chain Mapping
 Figure 70. Channels of Distribution (Direct Vs Distribution)
 Figure 71. Bottom-up and Top-down Approaches for This Report
 Figure 72. Data Triangulation
 Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Sex Hormones API Market Research Report 2024
Global Niche Active Pharmaceutical Ingredients API and Intermediates Market Research Report 2025
Chemical API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global NSAID API Market Research Report 2024
Api Drug Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sex Hormone APIs Market Research Report 2024
Global Peptide APIs Market Insights Forecast to 2030
API Derivatives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global High end Antibiotic Raw Materials Market Research Report 2024
Bulk Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biologic Peptide API Market Research Report 2024
Global Microbial Fermentation APIs Market Insights Forecast to 2030
Global Generic API Market Research Report 2025
Global Highly Potent API Market Insights Forecast to 2030
Global Glucocorticoid API Market Research Report 2024
Global Testosterone API Market Research Report 2025
Global Borax API Market Research Report 2025
Active Pharmaceutical Ingredient API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Acetaminophen API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bulk Drug Intermediates Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions